Barinthus Biotherapeutics (BRNS) SEC Filings & 10K Form

$2.50
+0.07 (+2.88%)
(As of 04/26/2024 ET)

Recent Barinthus Biotherapeutics SEC Filings

DateFilerForm TypeView
04/18/2024
3:15 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
7:36 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form DEF 14A
03/22/2024
7:41 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form DEFA14A
03/22/2024
7:43 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form ARS
03/20/2024
4:02 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2024
3:25 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2024
7:24 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
9:17 AM
Barinthus Biotherapeutics plc. (Subject)
Barinthus Biotherapeutics (Subject)
M&G INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G/A
01/05/2024
3:15 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:52 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Brown Gemma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:54 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Enright William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:55 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Griffiths Graham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:56 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Pelletier Nadege (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:01 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
10:04 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
4:19 PM
Vaccitech plc (Filer)
Barinthus Biotherapeutics (Filer)
Form PRE 14A
08/10/2023
7:47 AM
Vaccitech plc (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
7:12 AM
Vaccitech plc (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
6:52 AM
Scheeren Joseph (Reporting)
Vaccitech plc (Issuer)
Barinthus Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:05 PM
Vaccitech plc (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2023
7:16 AM
Vaccitech plc (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2023
7:19 AM
Vaccitech plc (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BRNS) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners